Option Millionaires

[thekrup]

Hi, I'm new to the board. I saw that downgrade for MRK this morning and the note of no catalysts is slightly confusing to me. The FDA is supposed to make a decision on their Hep C drug tomorrow. Also, I believe Keytruda is in about 200 different trials/drug combination trials. The CEO stated they are "chomping at the bit" for acquisitions in the size of $5 to $10 billion cap drug companies.

These days, I take analysts upgrades/downgrades with a "grain of salt". You see some downgrade a stock to "Hold" with a price target 20% higher than the current price or downgrade or upgrade a stock after it has already made big swings. Either way, it definitely didn't help the share price today along with the slide of the broader market.

I'm actually looking at getting some calls today in hopes their Hep C gets approved tomorrow and they price the drug aggressively to be competitive with Gilead's HEP C drug.